This finding is consistent with our earlier observation in a smaller cohort of breast cancer samples (Figure 1C) and indicates that in a significant proportion of the colorectal cancer cases with TFPI-2 silencing, there is an association with expression of the antisense RNA LCT13. Here, TFPI2 is linked to breast cancer.